EBMT NEWSLETTER | September 2017 | Volume 58 - Issue 4


EBMT International Transplant Course

Outcomes of the second edition of the ITC in Barcelona

Open Letter

Christian Chabannon's open letter to the EBMT community about the fundamental medical and scientific collaborations in and beyond Europe.

CAR-T cell therapy

FDA approved CAR-T cell therapy for children and young adults with B-cell ALL that is refractory or has relapsed at least twice. Read Prof. Nagler's interview about this important milestone.


Selection of EBMT recent publications published in peer-reviewed journals and Bone and Marrow Transplantation featured articles

EBMT Clinical Trials

Update on the RACE study

EBMT Annual Meeting

Abstract submission, preliminary program, registration; sponsorship and exhibition

Educational resources

Resource designed to educate healthcare professionals who are presented with ADA-SCID patients.

Legal & Regulatory Affairs

Update on the recent activities of the Legal & Regulatory Affairs Committee (LRAC)

Nurses News

VOD learning programme; abstract submission EBMT 2018; upcoming educational events; New committee member


Training courses; new inspectors; inspector recruiting; JACIE representation at events; JACIE Activity in 2017 to date; Accreditation awards

Important dates
Bookmark and Share